Coronavirus Disease 2019 Related Clinical Studies: A Cross-Sectional Analysis
ObjectiveThe quality and rationality of many recently registered clinical studies related to coronavirus disease 2019 (COVID-19) needs to be assessed. Hence, this study aims to evaluate the current status of COVID-19 related registered clinical trial.MethodsWe did an electronic search of COVID-19 re...
Main Authors: | Lin-Lu Ma, Xuan Yin, Bing-Hui Li, Jia-Yu Yang, Ying-Hui Jin, Di Huang, Tong Deng, Yun-Yun Wang, Xue-Qun Ren, Jianguang Ji, Xian-Tao Zeng |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2020-09-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fphar.2020.540187/full |
Similar Items
-
Overcoming non-compliance with clinical trial registration and results reporting: One Institution's approach
by: Sarah H. Snider, et al.
Published: (2020-06-01) -
Updated analysis of pediatric clinical studies registered in ClinicalTrials.gov, 2008–2019
by: Yang Zhong, et al.
Published: (2021-04-01) -
Clinical Trial Registration and Reporting: Drug Therapy and Prevention of Cardiac-Related Infections
by: Lin-Lu Ma, et al.
Published: (2019-07-01) -
Comprehensive Survey of Clinical Trials Registration for Melanoma Immunotherapy in the ClinicalTrials.gov
by: Yan-Bo Wang, et al.
Published: (2020-01-01) -
Comprehensive Analysis of Clinical Trials Registration for Lupus Nephritis Therapy on ClinicalTrials.gov
by: Yanfang Gao, et al.
Published: (2021-06-01)